Stoneridge Investment Partners LLC Acquires Shares of 4,065 Humana Inc. (NYSE:HUM)

Stoneridge Investment Partners LLC bought a new stake in Humana Inc. (NYSE:HUM) during the third quarter, HoldingsChannel.com reports. The institutional investor bought 4,065 shares of the insurance provider’s stock, valued at approximately $1,288,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Asset Management One Co. Ltd. raised its holdings in Humana by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 54,428 shares of the insurance provider’s stock valued at $17,240,000 after acquiring an additional 276 shares in the last quarter. National Pension Service increased its position in shares of Humana by 7.4% in the 3rd quarter. National Pension Service now owns 336,548 shares of the insurance provider’s stock worth $106,598,000 after purchasing an additional 23,100 shares during the last quarter. Intact Investment Management Inc. raised its stake in shares of Humana by 46.3% in the 3rd quarter. Intact Investment Management Inc. now owns 2,780 shares of the insurance provider’s stock valued at $881,000 after purchasing an additional 880 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its position in shares of Humana by 44.7% during the third quarter. Robeco Institutional Asset Management B.V. now owns 11,162 shares of the insurance provider’s stock worth $3,535,000 after purchasing an additional 3,447 shares during the last quarter. Finally, Van ECK Associates Corp bought a new position in shares of Humana during the third quarter worth about $424,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Down 2.0 %

HUM stock opened at $255.55 on Tuesday. The firm’s 50-day moving average is $295.11 and its two-hundred day moving average is $334.03. The company has a market capitalization of $30.77 billion, a price-to-earnings ratio of 22.64, a price-to-earnings-growth ratio of 2.02 and a beta of 0.52. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping the consensus estimate of $3.48 by $0.68. The firm had revenue of $29.30 billion for the quarter, compared to analysts’ expectations of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. On average, analysts forecast that Humana Inc. will post 16.15 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.39%. Humana’s dividend payout ratio is currently 31.36%.

Analysts Set New Price Targets

HUM has been the topic of several research reports. Barclays upped their price objective on Humana from $250.00 to $253.00 and gave the company an “equal weight” rating in a research note on Thursday, October 31st. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and reduced their price objective for the stock from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Truist Financial decreased their price objective on shares of Humana from $400.00 to $260.00 and set a “hold” rating for the company in a report on Friday, October 11th. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a report on Tuesday, October 8th. Finally, UBS Group decreased their price target on shares of Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. One research analyst has rated the stock with a sell rating, nineteen have issued a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $312.95.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.